US3925676A - Superconducting cyclotron neutron source for therapy - Google Patents

Superconducting cyclotron neutron source for therapy Download PDF

Info

Publication number
US3925676A
US3925676A US493415A US49341574A US3925676A US 3925676 A US3925676 A US 3925676A US 493415 A US493415 A US 493415A US 49341574 A US49341574 A US 49341574A US 3925676 A US3925676 A US 3925676A
Authority
US
United States
Prior art keywords
target
coils
cyclotron
ions
neutron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US493415A
Inventor
Clifford B Bigham
Harvey R Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atomic Energy of Canada Ltd AECL
Original Assignee
Atomic Energy of Canada Ltd AECL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atomic Energy of Canada Ltd AECL filed Critical Atomic Energy of Canada Ltd AECL
Priority to US493415A priority Critical patent/US3925676A/en
Priority to CA222,265A priority patent/CA1015469A/en
Priority to GB1300575A priority patent/GB1457860A/en
Priority to NL7506007A priority patent/NL7506007A/en
Priority to FR7522960A priority patent/FR2280399A1/en
Application granted granted Critical
Publication of US3925676A publication Critical patent/US3925676A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05HPLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
    • H05H3/00Production or acceleration of neutral particle beams, e.g. molecular or atomic beams
    • H05H3/06Generating neutron beams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05HPLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
    • H05H13/00Magnetic resonance accelerators; Cyclotrons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/109Neutrons

Definitions

  • a neutron source for medical therapy purposes comprising a cyclotron comprising an iron metal housing acting as a magnetic yoke, magnetic shield, radiation shield, and vacuum vessel, a pair of superconducting coils mounted in a cavity in the housing said coils being cooled to superconducting temperatures by passage of a refrigerant fluid therethrough and connected to an electrical energy source such that a high current flows in the coils producing an intense magnetic field inwardly between the coils, an ion orbiting region defined by pairs of sectoral-shaped RF electrode structures energized at an RF frequency and focussing flutter poles mounted in the intense magnetic field between coils, a source of ions positioned centrally of the ion orbiting region to provide a stream of ions that will be orbited in the orbit region; an ion target positioned internally of said iron housing at an outer position in the orbit region such that orbiting ions strike the target
  • a cyclotron source can provide the desired dose rate, say 120 rad/minute for one minute irradiations to obtain the desired depth-dose from a thin beryllium target requires a deuteron beam with an energy of about 25 MeV.
  • Conventional designs of cyclotrons capable of producing 25 MeV deuterons are very heavy and bulky (about 1 tonnes in weight). It is highly desirable that a neutron source for this purpose have an isocentric mounting for multiple beam directions in fractionated treatment. This would suggest the mounting of the neutron source on a gantry similar to that used for cobalt irradiators.
  • a neutron source comprising a cyclotron using an air core superconducting magnet to provide high intensity magnetic fields for producing a relatively high energy beam of ions, a target made of a material chosen from the group lighiurn, beryllium positioned in the ion beam path such that a high energy neutron beam is produced, and an isocentric mounting for said cyclotron and target.
  • FIG. 1 is a cross section of a superconducting cyclotron on an isocentric mounting
  • FIG. 2 is a cross section of the cyclotron showing the neutron beam from the internal target
  • FIG. 3 is a graph of the mid phase magnetic field of the cyclotron with and without flutter poles
  • FIG. 4 is a cross section of the cyclotron and the tar- FIG. 5A and 5B are midplane and vertical cross sec tions of the RF accelerating structure, and
  • FIG. 6A and 6B are vertical and midplane cross-sections of the ion source region.
  • a first type of neutron reaction considered for this 0 apparatus is the Be (d,n) B with a Q of 4.35 MeV.
  • the stripping reaction predominates so the output neutrons have about half of the deuteron energy.
  • the mean energy is about 0.36 E It has been found that a mean energy of about 14 MeV can be obtained with 25 MeV deuterons if the beryllium target is made about 50 mg/cm in thickness. The neutron yield is then approximately onethird that for a thick target requiring beam intensities about three times larger.
  • Other types of neutron reaction is Li(d,n) Be with Q of 15.0 MeV and Be(P,n) B with Q 1.9 MeV. The neutron yield from this reaction is a little smaller of the beryllium target yield at 16 MeV but the neutron spectrum has a higher mean energy and a component going to much higher energies.
  • a cyclotron 10 is mounted isocentrically by supports 11a and 11b on a strong, vertical, rotating pillar 11 such that the neutron beam 12 of the device can be moved over a fairly long arc.
  • the cyclotron has two superconducting coils 13 and 14 mounted in an iron housing 15 that has the combined function of a magnetic yoke, magnetic shield, radiation shield, and vacuum vessel.
  • the coils are mounted in a cavity in the iron housing in a radiation shield 16. Adjustments to the positioning of the coils can be made by means of a supporting and adjusting elements 17a, 17b, 17c, and 17d.
  • Helium cooling fluid and electrical leads to the coils pass through port 18 into the interior of shield 16.
  • An ion source 20 provides a stream of ions (deuterons or protons) that are introduced into the orbit region via passage 21. These ions orbit outwardly in the orbital region between plates 22 and 23 forming an RF resonator 36 mounted on RF input structures 24 and 25 and energized from an appropriate RF source via line 27.
  • a vacuum pump 28 connects to the internal cyclotron cavity via line 29 to provide the necessary vacuum level required for cyclotron operation.
  • Fig. 2 shows the described features and more detail of the four sector flutter pole geometry (sectors 34a, 34b, 34c, 34d) and the RF accelerating structure (resonator) 36.
  • the flutter poles provide azimuthal focussing and although four sectors are illustrated, other numbers e.g., three might be used. These are formed as raised portions of the iron housing structure leaving in effect four valley sectors 35a, 35b, 35c, 35d).
  • the superconducting coils in conjunction with the flutter poles provide an isochronous field profile to an outer radius R Since the energy level is fixed by design superconducting trim coils or normal trim coils are not required.
  • RF accelerating electrodes 36 are positioned in valleys 35a and 350 and are mounted on leg 24 and 25 extending axially to form a M2 resonator at 212.8 MHZ, four times the cyclotron frequency of 53.2 MHZ. A large energy gain per turn is not required since the beam is not extracted and orbit separation is not necessary.
  • the ions from the central ion source are extracted by the RF field and this determines the RF voltage required.
  • Typical beam power for a 200 ,u.A beam is KW.
  • An RF power of KW will drive the electrodes to about 20 KV peak with full beam.
  • the total weight of the cyclotron of beam power levels described above is about 4 tonnes. This compares favorably with the weight of shielding required for an isocentrically mounted cobalt-60 therapy head.
  • the design provides a minimum of 30 cm. of iron shielding.
  • FIG. 3 shows the required radial field profile for 25 MeV deuterons at a final orbit radious (R of cm.
  • the midplane magnetic field for isochronism is curve A. Because the flutter poles enhance the midplane field and also cause some radial variation in the azimuthally averaged field, the field profile required from the magnet coils is as shown by curve B which is the isochronous field with flutter pole field substracted.
  • FIG. 4 is a cross-section through the cyclotron showing the RF resonator 24 on one side and a flutter pole 3421 on the other. The latter is formed as part of the iron shield and vacuum vessel structure 15.
  • FIG. 5A and 5B shown the reasonator cavity 36 more clearly.
  • Two interconnected sectors are mounted in opposite valleys and joined at the centre to form a single ⁇ /2 resonator.
  • Two sectors instead of four give a simpler structure at the ion source.
  • the resonator is ener gized at RF by a probe loop 39 attached to leg 24 which may be a tube or rod. Other methods of energizaton may be used.
  • a large energy gain is not necessary but at least two sectors are necessary to provide symmetry.
  • An rf power of 10 KW should be sufficient to run the resonator at about 25 KV peak and supply a beam power up to about 5 KW (200 p.A at 25 MeV).
  • a fixed frequency system comprisng a stable oscillator, intermediate amplifier and power amplifier with 0.1 stability in power level and frequency would be adequate.
  • FIG. 6A and 6B show vertical and midplane sections of the ion source 21.
  • a tungsten filament arc source 37 in conjunction with a D gas stream provides a supply of deuterons into the orbit region 119. If protons are used as the ions, then an 11+ gas stream would be used.
  • a repeller electrode 38 causes the ion beam to travel in the correct paths to begin orbiting.
  • the azimuthal focussing is provided by a flutter field produced by iron poles extending to the end sheild which then forms a yoke. (See FIGS. 2 and 4).
  • B a flutter factor for h z 0.5
  • B a flutter factor for h z 0.5
  • At the extraction orbit 7 1.0133 for 25 MeV deuterons.
  • Using gives a maximum spiral angle if 45.
  • the flutter field cannot extend inward to the ion source so a magnetic hill is used to produce weak focussing out to where the flutter focussing becomes effective. This can be provided by a suitable rion shim in the central region.
  • the neutrons are generated in a 50 mg/cm thick beryllium metal layer on a 1 mm gold backing. Stopping the deuterons in gold after they pass through the beryllium reduces the low energy neutron flux.
  • the gold is in turn mounted on a water cooled copper backing.
  • the power in the beam is as large as SKW giving a power density of 1 KW/cm if the beam can be spread over 5 cm This is manageable but will require a carefully designed coolant channel with a water flow of about 2 gal. per minute. Under normal treatment conditions at rad per one minute fraction, the fractions will be repeated at 10-15 minute intervals i.e., the duty cycle is 10%.
  • the target assembly is mounted on a tube extending from the outside of the shielding and arranged so that it can be withdrawn into a vacuum lock for servicing.
  • a pair of coils with an inside diameter of 36.5 cm, a cross section of 12 cm x 12 cm and a separation of 13 cm, provides a field with approximately the correct magnitude and shape.
  • the maximum radial field is 3 Tesla.
  • the increase near the central region in the required coil field shown in curve B of FIG. 3 results from the flutter poles not extending to the cyclotron centre.
  • the conductor has the Nb Sn vapor deposited on a Hastelloy substrate and is clad on both sides with copper. Its dimensions are 0.5 inch wide X00072 in. thick. With this conductor, a coil as illustrated in FIG. 4 is made up of 9 pancake windings each with 400 turns. The total length of superconductor to wind two coils is then 11,300 metres. Total weight of superconductor is 210 Kgm and the weight of both coils with an inter coil bridge is 400 Kgm.
  • the coils are cooled by circulating supercritical liquid helium at 4.2 K around them.
  • the advantages of supercritical helium at a pressure above the critical value of 2.26 atm.,) as a cooling medium have been known but have not yet been extensively exploited.
  • the advantages are twofold; first high heat transfer coefficients are possible and second no difficulties caused by two phase flow of the helium can occur, since it is always maintained in the liquid state.
  • the disadvantage includes the requirement that the helium vessel around the coils must support a pressure greater than 3 atmospheres 4 atmospheres seems to be a good design value.
  • a neutron source for medical therapy purposes comprising:
  • a cyclotron comprising an iron metal housing acting as a magnetic yoke, magnetic shield, radiation shield, and vacuum vessel, a pair of superconducting coils mounted in a cavity in the housing said coils being cooled to superconducting temperatures by passage of a refrigerant fluid therethrough and connected to an electrical energy source such that a high current flows in the coils producing an intense magnetic field inwardly between the coils, an ion orbiting region defined by pairs of sectoralshaped RF electrode structures energized at an Rf frequency and focussing flutter poles mounted in the intense magnetic field between coils, a source of ions positioned centrally of the ion orbiting region to provide a stream of ions that will be orbited in the orbit region;
  • a mounting structure for movably mounting the cyclotron and target such that the neutron beam produced can be employed at more than one position.

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biomedical Technology (AREA)
  • Plasma & Fusion (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Particle Accelerators (AREA)

Abstract

A neutron source for medical therapy purposes comprising a cyclotron comprising an iron metal housing acting as a magnetic yoke, magnetic shield, radiation shield, and vacuum vessel, a pair of superconducting coils mounted in a cavity in the housing said coils being cooled to superconducting temperatures by passage of a refrigerant fluid therethrough and connected to an electrical energy source such that a high current flows in the coils producing an intense magnetic field inwardly between the coils, an ion orbiting region defined by pairs of sectoral-shaped RF electrode structures energized at an RF frequency and focussing flutter poles mounted in the intense magnetic field between coils, a source of ions positioned centrally of the ion orbiting region to provide a stream of ions that will be orbited in the orbit region; an ion target positioned internally of said iron housing at an outer position in the orbit region such that orbiting ions strike the target and produce neutrons; a channel formed in the iron housing from the target to the exterior for passage of the beam of neutrons formed at the target, said channel acting as a beam collimator; and a mounting structure for movably mounting the cyclotron and target such that the neutron beam produced can be employed at more than one position.

Description

[ Dec.9,1975
[ SERCONDUCTING CYCLOTRON NEUTRON SOURCE FOR THERAPY [75] Inventors: Cord B. Bigham; Harvey R. Schneider, both of Deep River, Canada [73] Assignee: Atomic Energy of Canada Limited, Ottawa, Canada [22] Filed: July 31, 1974 [21] Appl. No.: 493,415
Primary ExaminerDavis L. Willis Attorney, Agent, or FirmJames R. Hughes [57] STRACT A neutron source for medical therapy purposes comprising a cyclotron comprising an iron metal housing acting as a magnetic yoke, magnetic shield, radiation shield, and vacuum vessel, a pair of superconducting coils mounted in a cavity in the housing said coils being cooled to superconducting temperatures by passage of a refrigerant fluid therethrough and connected to an electrical energy source such that a high current flows in the coils producing an intense magnetic field inwardly between the coils, an ion orbiting region defined by pairs of sectoral-shaped RF electrode structures energized at an RF frequency and focussing flutter poles mounted in the intense magnetic field between coils, a source of ions positioned centrally of the ion orbiting region to provide a stream of ions that will be orbited in the orbit region; an ion target positioned internally of said iron housing at an outer position in the orbit region such that orbiting ions strike the target and produce neutrons; a channel formed in the iron housing from the target to the exterior for passage of the beam of neutrons formed at the target, said channel acting as a beam collimator; and a mounting structure for movably mounting the cyclotron and target such that the neutron beam produced can be employed at more than one position.
6 Claims, 8 Drawing Figures NEUTRON BEAM US. Patent Dec. 9, 1975 Sheet 1 of5 3,925,676
NEUTRON BEAM US. Patent Dec. 9, 1975 Sheet 2 of5 3,925,676
NEUTRON BEAM FIG. 2
(TESLA) MID PLANE MAGNETIC FIELD 6.2 I l a 1 O 20 4O 6O 80 I00 I20 I40 RADIUS (mm) PEG. 3
US. atant Dec. 9, 1975 Sheet 3 of5 3,925,676
FIG.4
CHANNEL EUTRO BEAM MID PLANE atent Dec. 9, 1975 Sheet 4 of 5 US. atsnt Dec. 9, 1975 Sheet 5 of5 3,925,67
HEPELLER FIG.6
SUPERCGNDUCTING CYCLOTRON NEUTRON SGURKIE FOR THERAPY This invention relates to a superconducting cyclotron neutron source for medical therapy purposes.
Recent experiments in the irradiation of tumors by neutrons have given encouraging results. One series of experiments were done with a 16 MeV deuteron beam on a beryllium target approximately 100 mg/cm thick. This provided a neutron spectrum with a mean energy about 8 MeV and a depth-dose of 43% at 10 cm. The does rate at a distance of 120 cm from the target for a 100 ,uA beam was about 50 rad per minute requiring 2.4 minutes for the usual required fraction of 120 rads. Although these results are quite good it is considered that higher mean neutron energy would improve the treatments. A depth dose 50% at 10 cm would appear to be desirable. This can be achieved with 14 MeV neutrons from a d-T (deuterium beam-tritium target) source at a source distance of 75 cm. A d-T source producing x n/sec. gives a dose rate of 30 rad/min. at 75 cm. The difficulty with d-T sources is in the target technology required to obtain higher dose rates, say 50 rad/min, with a reasonable target life. The present target lifetimes are unacceptable.
A cyclotron source can provide the desired dose rate, say 120 rad/minute for one minute irradiations to obtain the desired depth-dose from a thin beryllium target requires a deuteron beam with an energy of about 25 MeV. Conventional designs of cyclotrons capable of producing 25 MeV deuterons are very heavy and bulky (about 1 tonnes in weight). It is highly desirable that a neutron source for this purpose have an isocentric mounting for multiple beam directions in fractionated treatment. This would suggest the mounting of the neutron source on a gantry similar to that used for cobalt irradiators. it appears from this that a conventional cyclotron producing the required beam energy would have to have its beam extracted and transported to an isocentrically mounted target and this is out of the question for this application and would be uncompetitive with the d-T type source which is relatively small and which can be readily mounted in an isocentric manner.
It is therefore an object of the present invention to provide a neutron source for medical therapy that has high intensity is relatively light inweight, and which can be readily mounted isocentrically.
This and other objects of the invention are achieved by a neutron source comprising a cyclotron using an air core superconducting magnet to provide high intensity magnetic fields for producing a relatively high energy beam of ions, a target made of a material chosen from the group lighiurn, beryllium positioned in the ion beam path such that a high energy neutron beam is produced, and an isocentric mounting for said cyclotron and target.
A superconducting cyclotron of a type suitable for the present purpose is described in applicants pending application Ser. No. 419,034.
In drawings which illustrate an embodiment of the invention,
FIG. 1 is a cross section of a superconducting cyclotron on an isocentric mounting,
FIG. 2 is a cross section of the cyclotron showing the neutron beam from the internal target,
FIG. 3 is a graph of the mid phase magnetic field of the cyclotron with and without flutter poles,
FIG. 4 is a cross section of the cyclotron and the tar- FIG. 5A and 5B are midplane and vertical cross sec tions of the RF accelerating structure, and
FIG. 6A and 6B are vertical and midplane cross-sections of the ion source region.
A first type of neutron reaction considered for this 0 apparatus is the Be (d,n) B with a Q of 4.35 MeV. At
these energy levels, the stripping reaction predominates so the output neutrons have about half of the deuteron energy. For a thick target the mean energy is about 0.36 E It has been found that a mean energy of about 14 MeV can be obtained with 25 MeV deuterons if the beryllium target is made about 50 mg/cm in thickness. The neutron yield is then approximately onethird that for a thick target requiring beam intensities about three times larger. Other types of neutron reaction is Li(d,n) Be with Q of 15.0 MeV and Be(P,n) B with Q 1.9 MeV. The neutron yield from this reaction is a little smaller of the beryllium target yield at 16 MeV but the neutron spectrum has a higher mean energy and a component going to much higher energies. From known data, it is considered that a 25 MeV, a thick lithium target would have about twice the yield of a 50 mg/cm beryllium target, a mean energy of approximately 16 MeV and about Vs of the neutrons in a distribution extending to 26 MeV. These high energy neutrons would be very effective in the C (n,n 3 He and O (n,n 4 He reactions which are believed to be important in therapy.
Referring to FIG. 1 a cyclotron 10 is mounted isocentrically by supports 11a and 11b on a strong, vertical, rotating pillar 11 such that the neutron beam 12 of the device can be moved over a fairly long arc. The cyclotron has two superconducting coils 13 and 14 mounted in an iron housing 15 that has the combined function of a magnetic yoke, magnetic shield, radiation shield, and vacuum vessel. The coils are mounted in a cavity in the iron housing in a radiation shield 16. Adjustments to the positioning of the coils can be made by means of a supporting and adjusting elements 17a, 17b, 17c, and 17d. Helium cooling fluid and electrical leads to the coils pass through port 18 into the interior of shield 16. The coils are Nb, Sn superconductors providing a 7 tesla average magnetic field in orbit region 19 having a BR product of 1 for a deuteron output energy of 25 MeV (B field strength and R= radius). An ion source 20 provides a stream of ions (deuterons or protons) that are introduced into the orbit region via passage 21. These ions orbit outwardly in the orbital region between plates 22 and 23 forming an RF resonator 36 mounted on RF input structures 24 and 25 and energized from an appropriate RF source via line 27. A vacuum pump 28 connects to the internal cyclotron cavity via line 29 to provide the necessary vacuum level required for cyclotron operation. A target 30, either beam path inside the cyclotron as shown through port 31. Neutrons produced at the internal target pass through window 33 are collimated by a channel 32 in the magnet support spool and the iron yoke 15.
Fig. 2 shows the described features and more detail of the four sector flutter pole geometry ( sectors 34a, 34b, 34c, 34d) and the RF accelerating structure (resonator) 36. The flutter poles provide azimuthal focussing and although four sectors are illustrated, other numbers e.g., three might be used. These are formed as raised portions of the iron housing structure leaving in effect four valley sectors 35a, 35b, 35c, 35d). The superconducting coils in conjunction with the flutter poles provide an isochronous field profile to an outer radius R Since the energy level is fixed by design superconducting trim coils or normal trim coils are not required. RF accelerating electrodes 36 are positioned in valleys 35a and 350 and are mounted on leg 24 and 25 extending axially to form a M2 resonator at 212.8 MHZ, four times the cyclotron frequency of 53.2 MHZ. A large energy gain per turn is not required since the beam is not extracted and orbit separation is not necessary. The ions from the central ion source are extracted by the RF field and this determines the RF voltage required. Typical beam power for a 200 ,u.A beam is KW. An RF power of KW will drive the electrodes to about 20 KV peak with full beam.
The total weight of the cyclotron of beam power levels described above is about 4 tonnes. This compares favorably with the weight of shielding required for an isocentrically mounted cobalt-60 therapy head. The design provides a minimum of 30 cm. of iron shielding.
FIG. 3 shows the required radial field profile for 25 MeV deuterons at a final orbit radious (R of cm. The midplane magnetic field for isochronism is curve A. Because the flutter poles enhance the midplane field and also cause some radial variation in the azimuthally averaged field, the field profile required from the magnet coils is as shown by curve B which is the isochronous field with flutter pole field substracted.
FIG. 4 is a cross-section through the cyclotron showing the RF resonator 24 on one side and a flutter pole 3421 on the other. The latter is formed as part of the iron shield and vacuum vessel structure 15.
FIG. 5A and 5B shown the reasonator cavity 36 more clearly. Two interconnected sectors are mounted in opposite valleys and joined at the centre to form a single \/2 resonator. Two sectors instead of four give a simpler structure at the ion source. The resonator is ener gized at RF by a probe loop 39 attached to leg 24 which may be a tube or rod. Other methods of energizaton may be used. A large energy gain is not necessary but at least two sectors are necessary to provide symmetry. An rf power of 10 KW should be sufficient to run the resonator at about 25 KV peak and supply a beam power up to about 5 KW (200 p.A at 25 MeV). A fixed frequency system comprisng a stable oscillator, intermediate amplifier and power amplifier with 0.1 stability in power level and frequency would be adequate.
FIG. 6A and 6B show vertical and midplane sections of the ion source 21. A tungsten filament arc source 37 in conjunction with a D gas stream provides a supply of deuterons into the orbit region 119. If protons are used as the ions, then an 11+ gas stream would be used. A repeller electrode 38 causes the ion beam to travel in the correct paths to begin orbiting.
The azimuthal focussing is provided by a flutter field produced by iron poles extending to the end sheild which then forms a yoke. (See FIGS. 2 and 4). The estimated field increase between the poles AB 1.6 T giving for an average field, B, a flutter factor for h z 0.5 At the extraction orbit 7: 1.0133 for 25 MeV deuterons. Using gives a maximum spiral angle if 45. The flutter field cannot extend inward to the ion source so a magnetic hill is used to produce weak focussing out to where the flutter focussing becomes effective. This can be provided by a suitable rion shim in the central region. The radial betatron frequencey v 'y in the isochronous region reaching a maximum value of 1.0133. In the central hill region however v, 1 and must pass through unity at a small radius where imperfections could drive the V 1 resonance. This is not expected to cause difficulty since it would only spread the beam radially at the target.
The neutrons are generated in a 50 mg/cm thick beryllium metal layer on a 1 mm gold backing. Stopping the deuterons in gold after they pass through the beryllium reduces the low energy neutron flux. The gold is in turn mounted on a water cooled copper backing. The power in the beam is as large as SKW giving a power density of 1 KW/cm if the beam can be spread over 5 cm This is manageable but will require a carefully designed coolant channel with a water flow of about 2 gal. per minute. Under normal treatment conditions at rad per one minute fraction, the fractions will be repeated at 10-15 minute intervals i.e., the duty cycle is 10%. The target assembly is mounted on a tube extending from the outside of the shielding and arranged so that it can be withdrawn into a vacuum lock for servicing.
In a typical design, a pair of coils with an inside diameter of 36.5 cm, a cross section of 12 cm x 12 cm and a separation of 13 cm, provides a field with approximately the correct magnitude and shape. There are 1.8 x 10 ampere turns in each coil. This corresponds to an overall current density of 12,500 A/cm which is within the state of the art for niobium-tin coils. The maximum radial field is 3 Tesla. The increase near the central region in the required coil field shown in curve B of FIG. 3 results from the flutter poles not extending to the cyclotron centre.
Lorentz forces within the coils are large but tractable. The maximum hoop stress, which occurs at the inside winding is approximately 30,000 psi assuming no transfer of the radial force to the outer windings. If such transfer is assumed so that a uniform hoop stress is realized, then its value would be no greater than 15,000 psi. The tensile strength of stainless steel is considerably larger than this at low temperatures so no problems are expexted here. Two types of superconductor may be used in winding the coils, Nb SN and V Ga. The first of these is commercially available and has a guaranteed short sample critical current of 600 amperes at 10 Tesla and 4.2K. The conductor has the Nb Sn vapor deposited on a Hastelloy substrate and is clad on both sides with copper. Its dimensions are 0.5 inch wide X00072 in. thick. With this conductor, a coil as illustrated in FIG. 4 is made up of 9 pancake windings each with 400 turns. The total length of superconductor to wind two coils is then 11,300 metres. Total weight of superconductor is 210 Kgm and the weight of both coils with an inter coil bridge is 400 Kgm.
The coils are cooled by circulating supercritical liquid helium at 4.2 K around them. The advantages of supercritical helium at a pressure above the critical value of 2.26 atm.,) as a cooling medium have been known but have not yet been extensively exploited. For the present application the advantages are twofold; first high heat transfer coefficients are possible and second no difficulties caused by two phase flow of the helium can occur, since it is always maintained in the liquid state. The disadvantage includes the requirement that the helium vessel around the coils must support a pressure greater than 3 atmospheres 4 atmospheres seems to be a good design value.
We claim:
1. A neutron source for medical therapy purposes comprising:
a. a cyclotron comprising an iron metal housing acting as a magnetic yoke, magnetic shield, radiation shield, and vacuum vessel, a pair of superconducting coils mounted in a cavity in the housing said coils being cooled to superconducting temperatures by passage of a refrigerant fluid therethrough and connected to an electrical energy source such that a high current flows in the coils producing an intense magnetic field inwardly between the coils, an ion orbiting region defined by pairs of sectoralshaped RF electrode structures energized at an Rf frequency and focussing flutter poles mounted in the intense magnetic field between coils, a source of ions positioned centrally of the ion orbiting region to provide a stream of ions that will be orbited in the orbit region;
b. an ion target positioned internally of said iron housing at an outer position in the orbit region such that orbiting ions strike the target and produce neutrons;
c. a channel formed in the iron housing from the target to the exterior for passage of the beam of neutrons formed at the target, said channel acting as a beam collimator; and
d. a mounting structure for movably mounting the cyclotron and target such that the neutron beam produced can be employed at more than one position.
2. A neutron source as in claim ll wherein the ions orbited in the cyclotron are deuterons and the target is a thick beryllium metal layer.
3. A neutron source as in claim 1 wherein the ions orbited in the cyclotron are deuterons and the target is a thick lithium metal layer.
4. A neutron source as in claim 1 wherein the mounting structure is a gantry allowing movement of the cyclotron and thus the neutron beam in an isocentric path.
5. A neutron source as in claim 1 wherein the flutter poles are four in number and are formed as spiraledged sectoral raised portions of the iron housing structure defining valleys between with the said RF electrode structures being positioned in the valley regions.
6. A neutron source as in claim 1 wherein the refrigerant fluid is supercritical helium at a temperature of 4.2K.

Claims (6)

1. A neutron source for medical therapy purposes comprising: a. a cyclotron comprising an iron metal housing acting as a magnetic yoke, magnetic shield, radiation shield, and vacuum vessel, a pair of superconducting coils mounted in a cavity in the housing said coils being cooled to superconducting temperatures by passage of a refrigerant fluid therethrough and connected to an electrical energy source such that a high current flows in the coils producing an intense magnetic field inwardly between the coils, an ion orbiting region defined by pairs of sectoral-shaped RF electrode structures energized at an Rf frequency and focussing flutter poles mounted in the intense magnetic field between coils, a source of ions positioned centrally of the ion orbiting region to provide a stream of ions that will be orbited in the orbit region; b. an ion target positioned internally of said iron housing at an outer position in the orbit region such that orbiting ions strike the target and produce neutrons; c. a channel formed in the iron housing from the target to the exterior for passage of the beam of neutrons formed at the target, said channel acting as a beam collimator; and d. a mounting structure for movably mounting the cyclotron and target such that the neutron beam produced can be employed at more than one position.
2. A neutron source as in claim 1 wherein the ions orbited in the cyclotron are deuterons and the target is a thick beryllium metal layer.
3. A neutron source as in claim 1 wherein the ions orbited in the cyclotron are deuterons and the target is a thick lithium metal layer.
4. A neutron source as in claim 1 wherein the mounting structure is a gantry allowing movement of the cyclotron and thus the neutron beam in an isocentric path.
5. A neutron source as in claim 1 wherein the flutter poles are four in number and are formed as spiral-edged sectoral raised portions of the iron housing structure defining valleys between with the said RF electrode structures being positioned in the valley regions.
6. A neutron source as in claim 1 wherein the refrigerant fluid is supercritical helium at a temperature of 4.2K.
US493415A 1974-07-31 1974-07-31 Superconducting cyclotron neutron source for therapy Expired - Lifetime US3925676A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US493415A US3925676A (en) 1974-07-31 1974-07-31 Superconducting cyclotron neutron source for therapy
CA222,265A CA1015469A (en) 1974-07-31 1975-03-17 Superconducting cyclotron neutron source for therapy
GB1300575A GB1457860A (en) 1974-07-31 1975-04-01 Neutron sources for medical therapy
NL7506007A NL7506007A (en) 1974-07-31 1975-05-22 SUPER CONDUCTIVE CYCLOTRON AS A NEUTRON SOURCE FOR THERAPEUTIC PURPOSES.
FR7522960A FR2280399A1 (en) 1974-07-31 1975-07-23 SOURCE OF NEUTRONS TO CYCLOTRON WITH UPPER-CONDUCTIVE WINDINGS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US493415A US3925676A (en) 1974-07-31 1974-07-31 Superconducting cyclotron neutron source for therapy

Publications (1)

Publication Number Publication Date
US3925676A true US3925676A (en) 1975-12-09

Family

ID=23960140

Family Applications (1)

Application Number Title Priority Date Filing Date
US493415A Expired - Lifetime US3925676A (en) 1974-07-31 1974-07-31 Superconducting cyclotron neutron source for therapy

Country Status (5)

Country Link
US (1) US3925676A (en)
CA (1) CA1015469A (en)
FR (1) FR2280399A1 (en)
GB (1) GB1457860A (en)
NL (1) NL7506007A (en)

Cited By (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112306A (en) * 1976-12-06 1978-09-05 Varian Associates, Inc. Neutron irradiation therapy machine
US4139777A (en) * 1975-11-19 1979-02-13 Rautenbach Willem L Cyclotron and neutron therapy installation incorporating such a cyclotron
US4599515A (en) * 1984-01-20 1986-07-08 Ga Technologies Inc. Moderator and beam port assembly for neutron radiography
WO1986006924A1 (en) * 1985-05-10 1986-11-20 Universite Catholique De Louvain Cyclotron
US4641104A (en) * 1984-04-26 1987-02-03 Board Of Trustees Operating Michigan State University Superconducting medical cyclotron
US4705955A (en) * 1985-04-02 1987-11-10 Curt Mileikowsky Radiation therapy for cancer patients
US4943781A (en) * 1985-05-21 1990-07-24 Oxford Instruments, Ltd. Cyclotron with yokeless superconducting magnet
US20030174800A1 (en) * 2002-03-12 2003-09-18 Hidetsugu Ikegami And Sayaka Ikegami Method of and apparatus for generating recoilless nonthermal nuclear fusion
US20030231731A1 (en) * 2002-06-17 2003-12-18 Hidetsugu Ikegami Method of controlling temperature of nonthermal nuclear fusion fuel in nonthermal nuclear fusion reaction generating method
US6683426B1 (en) * 1999-07-13 2004-01-27 Ion Beam Applications S.A. Isochronous cyclotron and method of extraction of charged particles from such cyclotron
WO2007084701A1 (en) * 2006-01-19 2007-07-26 Massachusetts Institute Of Technology Magnet structure for particle acceleration
US20070176699A1 (en) * 2005-03-29 2007-08-02 Japan As Represented By The President Of National Cardiovascular Center Particle beam accelerator
WO2008083721A1 (en) * 2006-12-21 2008-07-17 Accel Instruments Gmbh Radiation apparatus
US7656258B1 (en) 2006-01-19 2010-02-02 Massachusetts Institute Of Technology Magnet structure for particle acceleration
US7728311B2 (en) 2005-11-18 2010-06-01 Still River Systems Incorporated Charged particle radiation therapy
EP2223326A2 (en) * 2007-11-13 2010-09-01 Kaonetics Technologies, Inc. Directed-energy systems and methods for disrupting electronic circuits
US20100282979A1 (en) * 2009-05-05 2010-11-11 Jonas Norling Isotope production system and cyclotron having a magnet yoke with a pump acceptance cavity
US20100283371A1 (en) * 2009-05-05 2010-11-11 Jonas Norling Isotope production system and cyclotron having reduced magnetic stray fields
US8003964B2 (en) 2007-10-11 2011-08-23 Still River Systems Incorporated Applying a particle beam to a patient
US8153997B2 (en) 2009-05-05 2012-04-10 General Electric Company Isotope production system and cyclotron
WO2013006182A1 (en) * 2011-07-07 2013-01-10 Ionetix Corporation Compact, cold, superconducting isochronous cyclotron
US8374306B2 (en) 2009-06-26 2013-02-12 General Electric Company Isotope production system with separated shielding
US8581523B2 (en) 2007-11-30 2013-11-12 Mevion Medical Systems, Inc. Interrupted particle source
US8791656B1 (en) 2013-05-31 2014-07-29 Mevion Medical Systems, Inc. Active return system
TWI458397B (en) * 2006-08-09 2014-10-21 Massachusetts Inst Technology Magnet structure for particle acceleration
US8927950B2 (en) 2012-09-28 2015-01-06 Mevion Medical Systems, Inc. Focusing a particle beam
US8933650B2 (en) 2007-11-30 2015-01-13 Mevion Medical Systems, Inc. Matching a resonant frequency of a resonant cavity to a frequency of an input voltage
US8952634B2 (en) 2004-07-21 2015-02-10 Mevion Medical Systems, Inc. Programmable radio frequency waveform generator for a synchrocyclotron
US9155186B2 (en) 2012-09-28 2015-10-06 Mevion Medical Systems, Inc. Focusing a particle beam using magnetic field flutter
US9185789B2 (en) 2012-09-28 2015-11-10 Mevion Medical Systems, Inc. Magnetic shims to alter magnetic fields
US9301384B2 (en) 2012-09-28 2016-03-29 Mevion Medical Systems, Inc. Adjusting energy of a particle beam
CN106132065A (en) * 2016-07-29 2016-11-16 中国原子能科学研究院 230MeV superconducting cyclotron avoids the field structure of draw-out area harmful resonance
CN106231778A (en) * 2016-08-31 2016-12-14 安徽思讯医疗科技有限公司 The radioisotopic superconducting cyclotron of a kind of production
US9545528B2 (en) 2012-09-28 2017-01-17 Mevion Medical Systems, Inc. Controlling particle therapy
US20170069415A1 (en) * 2014-03-13 2017-03-09 Forschungszentrum Juelich Gmbh Superconducting magnetic field stabilizer
US9622335B2 (en) 2012-09-28 2017-04-11 Mevion Medical Systems, Inc. Magnetic field regenerator
US9661736B2 (en) 2014-02-20 2017-05-23 Mevion Medical Systems, Inc. Scanning system for a particle therapy system
US9681531B2 (en) 2012-09-28 2017-06-13 Mevion Medical Systems, Inc. Control system for a particle accelerator
US9723705B2 (en) 2012-09-28 2017-08-01 Mevion Medical Systems, Inc. Controlling intensity of a particle beam
US9730308B2 (en) 2013-06-12 2017-08-08 Mevion Medical Systems, Inc. Particle accelerator that produces charged particles having variable energies
US9734926B2 (en) 2008-05-02 2017-08-15 Shine Medical Technologies, Inc. Device and method for producing medical isotopes
US9950194B2 (en) 2014-09-09 2018-04-24 Mevion Medical Systems, Inc. Patient positioning system
US9962560B2 (en) 2013-12-20 2018-05-08 Mevion Medical Systems, Inc. Collimator and energy degrader
EP3305038A4 (en) * 2015-05-26 2019-01-16 Antaya Science & Technology Isochronous cyclotron with superconducting flutter coils and non-magnetic reinforcement
CN109343103A (en) * 2018-09-11 2019-02-15 东莞中子科学中心 A kind of vacuum air-channel system for charged particle detection spectrometer vacuum target chamber
US10254739B2 (en) 2012-09-28 2019-04-09 Mevion Medical Systems, Inc. Coil positioning system
US10258810B2 (en) 2013-09-27 2019-04-16 Mevion Medical Systems, Inc. Particle beam scanning
US10556127B2 (en) * 2016-07-04 2020-02-11 Neuboron Medtech Ltd. Neutron therapy apparatus
US10646728B2 (en) 2015-11-10 2020-05-12 Mevion Medical Systems, Inc. Adaptive aperture
US10653892B2 (en) 2017-06-30 2020-05-19 Mevion Medical Systems, Inc. Configurable collimator controlled using linear motors
US10675487B2 (en) 2013-12-20 2020-06-09 Mevion Medical Systems, Inc. Energy degrader enabling high-speed energy switching
US10734126B2 (en) 2011-04-28 2020-08-04 SHINE Medical Technologies, LLC Methods of separating medical isotopes from uranium solutions
US10744345B2 (en) * 2016-07-04 2020-08-18 Neuboron Medtech Ltd. Neutron therapy apparatus
US10925147B2 (en) 2016-07-08 2021-02-16 Mevion Medical Systems, Inc. Treatment planning
US10978214B2 (en) 2010-01-28 2021-04-13 SHINE Medical Technologies, LLC Segmented reaction chamber for radioisotope production
US11103730B2 (en) 2017-02-23 2021-08-31 Mevion Medical Systems, Inc. Automated treatment in particle therapy
CN113597081A (en) * 2021-09-16 2021-11-02 中国科学院近代物理研究所 Method for locally heating tin source in superconducting cavity
US11291861B2 (en) 2019-03-08 2022-04-05 Mevion Medical Systems, Inc. Delivery of radiation by column and generating a treatment plan therefor
US11361873B2 (en) 2012-04-05 2022-06-14 Shine Technologies, Llc Aqueous assembly and control method
CN115460759A (en) * 2022-11-08 2022-12-09 合肥中科离子医学技术装备有限公司 Cyclotron

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733490A (en) * 1971-01-08 1973-05-15 En Atomique Rotary target for electrostatic accelerator which operates as a neutron generator
US3860827A (en) * 1972-09-05 1975-01-14 Lawrence Cranberg Neutron generator target assembly

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733490A (en) * 1971-01-08 1973-05-15 En Atomique Rotary target for electrostatic accelerator which operates as a neutron generator
US3860827A (en) * 1972-09-05 1975-01-14 Lawrence Cranberg Neutron generator target assembly

Cited By (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139777A (en) * 1975-11-19 1979-02-13 Rautenbach Willem L Cyclotron and neutron therapy installation incorporating such a cyclotron
US4112306A (en) * 1976-12-06 1978-09-05 Varian Associates, Inc. Neutron irradiation therapy machine
US4599515A (en) * 1984-01-20 1986-07-08 Ga Technologies Inc. Moderator and beam port assembly for neutron radiography
US4641104A (en) * 1984-04-26 1987-02-03 Board Of Trustees Operating Michigan State University Superconducting medical cyclotron
US4705955A (en) * 1985-04-02 1987-11-10 Curt Mileikowsky Radiation therapy for cancer patients
WO1986006924A1 (en) * 1985-05-10 1986-11-20 Universite Catholique De Louvain Cyclotron
US4943781A (en) * 1985-05-21 1990-07-24 Oxford Instruments, Ltd. Cyclotron with yokeless superconducting magnet
US6683426B1 (en) * 1999-07-13 2004-01-27 Ion Beam Applications S.A. Isochronous cyclotron and method of extraction of charged particles from such cyclotron
US20030174800A1 (en) * 2002-03-12 2003-09-18 Hidetsugu Ikegami And Sayaka Ikegami Method of and apparatus for generating recoilless nonthermal nuclear fusion
US20030231731A1 (en) * 2002-06-17 2003-12-18 Hidetsugu Ikegami Method of controlling temperature of nonthermal nuclear fusion fuel in nonthermal nuclear fusion reaction generating method
US7888891B2 (en) * 2004-03-29 2011-02-15 National Cerebral And Cardiovascular Center Particle beam accelerator
US8952634B2 (en) 2004-07-21 2015-02-10 Mevion Medical Systems, Inc. Programmable radio frequency waveform generator for a synchrocyclotron
USRE48047E1 (en) 2004-07-21 2020-06-09 Mevion Medical Systems, Inc. Programmable radio frequency waveform generator for a synchrocyclotron
US20070176699A1 (en) * 2005-03-29 2007-08-02 Japan As Represented By The President Of National Cardiovascular Center Particle beam accelerator
US9925395B2 (en) 2005-11-18 2018-03-27 Mevion Medical Systems, Inc. Inner gantry
US9452301B2 (en) 2005-11-18 2016-09-27 Mevion Medical Systems, Inc. Inner gantry
US10722735B2 (en) 2005-11-18 2020-07-28 Mevion Medical Systems, Inc. Inner gantry
US10279199B2 (en) 2005-11-18 2019-05-07 Mevion Medical Systems, Inc. Inner gantry
US8916843B2 (en) 2005-11-18 2014-12-23 Mevion Medical Systems, Inc. Inner gantry
US8907311B2 (en) 2005-11-18 2014-12-09 Mevion Medical Systems, Inc. Charged particle radiation therapy
US8344340B2 (en) 2005-11-18 2013-01-01 Mevion Medical Systems, Inc. Inner gantry
US7728311B2 (en) 2005-11-18 2010-06-01 Still River Systems Incorporated Charged particle radiation therapy
US7541905B2 (en) * 2006-01-19 2009-06-02 Massachusetts Institute Of Technology High-field superconducting synchrocyclotron
WO2007130164A3 (en) * 2006-01-19 2008-04-10 Massachusetts Inst Technology High-field superconducting synchrocyclotron
US20090206967A1 (en) * 2006-01-19 2009-08-20 Massachusetts Institute Of Technology High-Field Synchrocyclotron
WO2007084701A1 (en) * 2006-01-19 2007-07-26 Massachusetts Institute Of Technology Magnet structure for particle acceleration
US20070171015A1 (en) * 2006-01-19 2007-07-26 Massachusetts Institute Of Technology High-Field Superconducting Synchrocyclotron
US7656258B1 (en) 2006-01-19 2010-02-02 Massachusetts Institute Of Technology Magnet structure for particle acceleration
JP2009524200A (en) * 2006-01-19 2009-06-25 マサチューセッツ・インスティテュート・オブ・テクノロジー Magnet structure for particle acceleration
JP2009524201A (en) * 2006-01-19 2009-06-25 マサチューセッツ・インスティテュート・オブ・テクノロジー High-field superconducting synchrocyclotron
WO2007130164A2 (en) * 2006-01-19 2007-11-15 Massachusetts Institute Of Technology High-field superconducting synchrocyclotron
US7696847B2 (en) * 2006-01-19 2010-04-13 Massachusetts Institute Of Technology High-field synchrocyclotron
TWI458397B (en) * 2006-08-09 2014-10-21 Massachusetts Inst Technology Magnet structure for particle acceleration
WO2008083721A1 (en) * 2006-12-21 2008-07-17 Accel Instruments Gmbh Radiation apparatus
US8053746B2 (en) 2006-12-21 2011-11-08 Varian Medical Systems Particle Therapy Gmbh Irradiation device
US20090321665A1 (en) * 2006-12-21 2009-12-31 Varian Medical Systems Particle Therapy Gmbh Irradiation Device
US8941083B2 (en) 2007-10-11 2015-01-27 Mevion Medical Systems, Inc. Applying a particle beam to a patient
US8003964B2 (en) 2007-10-11 2011-08-23 Still River Systems Incorporated Applying a particle beam to a patient
EP2223326A4 (en) * 2007-11-13 2012-03-14 Kaonetics Technologies Inc Directed-energy systems and methods for disrupting electronic circuits
EP2223326A2 (en) * 2007-11-13 2010-09-01 Kaonetics Technologies, Inc. Directed-energy systems and methods for disrupting electronic circuits
US8970137B2 (en) 2007-11-30 2015-03-03 Mevion Medical Systems, Inc. Interrupted particle source
US8581523B2 (en) 2007-11-30 2013-11-12 Mevion Medical Systems, Inc. Interrupted particle source
USRE48317E1 (en) 2007-11-30 2020-11-17 Mevion Medical Systems, Inc. Interrupted particle source
US8933650B2 (en) 2007-11-30 2015-01-13 Mevion Medical Systems, Inc. Matching a resonant frequency of a resonant cavity to a frequency of an input voltage
US11830637B2 (en) 2008-05-02 2023-11-28 Shine Technologies, Llc Device and method for producing medical isotopes
US9734926B2 (en) 2008-05-02 2017-08-15 Shine Medical Technologies, Inc. Device and method for producing medical isotopes
JP2012526357A (en) * 2009-05-05 2012-10-25 ゼネラル・エレクトリック・カンパニイ Isotope generation system and cyclotron with reduced stray field
US20100283371A1 (en) * 2009-05-05 2010-11-11 Jonas Norling Isotope production system and cyclotron having reduced magnetic stray fields
JP2012526356A (en) * 2009-05-05 2012-10-25 ゼネラル・エレクトリック・カンパニイ Isotope production system and cyclotron
US8106370B2 (en) 2009-05-05 2012-01-31 General Electric Company Isotope production system and cyclotron having a magnet yoke with a pump acceptance cavity
US8153997B2 (en) 2009-05-05 2012-04-10 General Electric Company Isotope production system and cyclotron
US8106570B2 (en) 2009-05-05 2012-01-31 General Electric Company Isotope production system and cyclotron having reduced magnetic stray fields
KR20120020111A (en) * 2009-05-05 2012-03-07 제너럴 일렉트릭 캄파니 Isotope production system and cyclotron having reduced magnetic stray fields
US20100282979A1 (en) * 2009-05-05 2010-11-11 Jonas Norling Isotope production system and cyclotron having a magnet yoke with a pump acceptance cavity
US8374306B2 (en) 2009-06-26 2013-02-12 General Electric Company Isotope production system with separated shielding
US10978214B2 (en) 2010-01-28 2021-04-13 SHINE Medical Technologies, LLC Segmented reaction chamber for radioisotope production
US11894157B2 (en) 2010-01-28 2024-02-06 Shine Technologies, Llc Segmented reaction chamber for radioisotope production
US10734126B2 (en) 2011-04-28 2020-08-04 SHINE Medical Technologies, LLC Methods of separating medical isotopes from uranium solutions
TWI559822B (en) * 2011-07-07 2016-11-21 伊歐尼蒂克斯公司 Compact, cold, superconducting isochronous cyclotron
WO2013006182A1 (en) * 2011-07-07 2013-01-10 Ionetix Corporation Compact, cold, superconducting isochronous cyclotron
US8558485B2 (en) 2011-07-07 2013-10-15 Ionetix Corporation Compact, cold, superconducting isochronous cyclotron
US11361873B2 (en) 2012-04-05 2022-06-14 Shine Technologies, Llc Aqueous assembly and control method
US9185789B2 (en) 2012-09-28 2015-11-10 Mevion Medical Systems, Inc. Magnetic shims to alter magnetic fields
US9155186B2 (en) 2012-09-28 2015-10-06 Mevion Medical Systems, Inc. Focusing a particle beam using magnetic field flutter
US9723705B2 (en) 2012-09-28 2017-08-01 Mevion Medical Systems, Inc. Controlling intensity of a particle beam
US9706636B2 (en) 2012-09-28 2017-07-11 Mevion Medical Systems, Inc. Adjusting energy of a particle beam
US9681531B2 (en) 2012-09-28 2017-06-13 Mevion Medical Systems, Inc. Control system for a particle accelerator
US10368429B2 (en) 2012-09-28 2019-07-30 Mevion Medical Systems, Inc. Magnetic field regenerator
US8927950B2 (en) 2012-09-28 2015-01-06 Mevion Medical Systems, Inc. Focusing a particle beam
US9622335B2 (en) 2012-09-28 2017-04-11 Mevion Medical Systems, Inc. Magnetic field regenerator
US10155124B2 (en) 2012-09-28 2018-12-18 Mevion Medical Systems, Inc. Controlling particle therapy
US9301384B2 (en) 2012-09-28 2016-03-29 Mevion Medical Systems, Inc. Adjusting energy of a particle beam
US9545528B2 (en) 2012-09-28 2017-01-17 Mevion Medical Systems, Inc. Controlling particle therapy
US10254739B2 (en) 2012-09-28 2019-04-09 Mevion Medical Systems, Inc. Coil positioning system
US8791656B1 (en) 2013-05-31 2014-07-29 Mevion Medical Systems, Inc. Active return system
US9730308B2 (en) 2013-06-12 2017-08-08 Mevion Medical Systems, Inc. Particle accelerator that produces charged particles having variable energies
US10258810B2 (en) 2013-09-27 2019-04-16 Mevion Medical Systems, Inc. Particle beam scanning
US10456591B2 (en) 2013-09-27 2019-10-29 Mevion Medical Systems, Inc. Particle beam scanning
US10675487B2 (en) 2013-12-20 2020-06-09 Mevion Medical Systems, Inc. Energy degrader enabling high-speed energy switching
US9962560B2 (en) 2013-12-20 2018-05-08 Mevion Medical Systems, Inc. Collimator and energy degrader
US9661736B2 (en) 2014-02-20 2017-05-23 Mevion Medical Systems, Inc. Scanning system for a particle therapy system
US11717700B2 (en) 2014-02-20 2023-08-08 Mevion Medical Systems, Inc. Scanning system
US10434331B2 (en) 2014-02-20 2019-10-08 Mevion Medical Systems, Inc. Scanning system
US10497503B2 (en) * 2014-03-13 2019-12-03 Forschungszentrum Juelich Gmbh Superconducting magnetic field stabilizer
US20170069415A1 (en) * 2014-03-13 2017-03-09 Forschungszentrum Juelich Gmbh Superconducting magnetic field stabilizer
US9950194B2 (en) 2014-09-09 2018-04-24 Mevion Medical Systems, Inc. Patient positioning system
EP3305038A4 (en) * 2015-05-26 2019-01-16 Antaya Science & Technology Isochronous cyclotron with superconducting flutter coils and non-magnetic reinforcement
US10786689B2 (en) 2015-11-10 2020-09-29 Mevion Medical Systems, Inc. Adaptive aperture
US11213697B2 (en) 2015-11-10 2022-01-04 Mevion Medical Systems, Inc. Adaptive aperture
US10646728B2 (en) 2015-11-10 2020-05-12 Mevion Medical Systems, Inc. Adaptive aperture
US11786754B2 (en) 2015-11-10 2023-10-17 Mevion Medical Systems, Inc. Adaptive aperture
US10556127B2 (en) * 2016-07-04 2020-02-11 Neuboron Medtech Ltd. Neutron therapy apparatus
US10744345B2 (en) * 2016-07-04 2020-08-18 Neuboron Medtech Ltd. Neutron therapy apparatus
US10925147B2 (en) 2016-07-08 2021-02-16 Mevion Medical Systems, Inc. Treatment planning
CN106132065A (en) * 2016-07-29 2016-11-16 中国原子能科学研究院 230MeV superconducting cyclotron avoids the field structure of draw-out area harmful resonance
CN106231778A (en) * 2016-08-31 2016-12-14 安徽思讯医疗科技有限公司 The radioisotopic superconducting cyclotron of a kind of production
US11103730B2 (en) 2017-02-23 2021-08-31 Mevion Medical Systems, Inc. Automated treatment in particle therapy
US10653892B2 (en) 2017-06-30 2020-05-19 Mevion Medical Systems, Inc. Configurable collimator controlled using linear motors
CN109343103A (en) * 2018-09-11 2019-02-15 东莞中子科学中心 A kind of vacuum air-channel system for charged particle detection spectrometer vacuum target chamber
US11291861B2 (en) 2019-03-08 2022-04-05 Mevion Medical Systems, Inc. Delivery of radiation by column and generating a treatment plan therefor
US11717703B2 (en) 2019-03-08 2023-08-08 Mevion Medical Systems, Inc. Delivery of radiation by column and generating a treatment plan therefor
US11311746B2 (en) 2019-03-08 2022-04-26 Mevion Medical Systems, Inc. Collimator and energy degrader for a particle therapy system
CN113597081B (en) * 2021-09-16 2023-07-25 中国科学院近代物理研究所 Method for locally heating tin source in superconducting cavity
CN113597081A (en) * 2021-09-16 2021-11-02 中国科学院近代物理研究所 Method for locally heating tin source in superconducting cavity
CN115460759A (en) * 2022-11-08 2022-12-09 合肥中科离子医学技术装备有限公司 Cyclotron

Also Published As

Publication number Publication date
GB1457860A (en) 1976-12-08
FR2280399B1 (en) 1978-07-28
FR2280399A1 (en) 1976-02-27
CA1015469A (en) 1977-08-09
NL7506007A (en) 1976-02-03

Similar Documents

Publication Publication Date Title
US3925676A (en) Superconducting cyclotron neutron source for therapy
JP6804581B2 (en) Active return system and proton therapy system
US8975836B2 (en) Ultra-light, magnetically shielded, high-current, compact cyclotron
US9706636B2 (en) Adjusting energy of a particle beam
JP6441508B2 (en) Isochronous cyclotron with superconducting flutter coil and non-magnetic reinforcement
Khiari et al. Acceleration of polarized protons to 22 GeV/c and the measurement of spin-spin effects in p↑+ p↑→ p+p
EP2901820B1 (en) Focusing a particle beam using magnetic field flutter
Gusev et al. Globus-M spherical tokamak
US10028369B2 (en) Particle acceleration in a variable-energy synchrocyclotron by a single-tuned variable-frequency drive
JP4356019B2 (en) Electron accelerator and radiotherapy apparatus using the same
US3577317A (en) Controlled fusion reactor
Holm et al. New accelerators in Uppsala
Clendenin High-yield positron systems for linear colliders
Marks et al. Initial operation of a 5 T superconducting wiggler magnet in the SRS
Pavlichenko First results from the'URAGAN-2M'torsatron
Schippers Proton accelerators
Botman et al. Extraction from cyclotrons
Schneider et al. Superconducting cyclotrons
Martin A proton accelerator for medical applications
Hepburn et al. Superconducting cyclotron neutron source for therapy
Takahashi Compact SR light source for x-ray lithography
Cho et al. A 10-GeV, 5-MW proton source for a pulsed spallation source
Sugimura Proton linear accelerator and beryllium target system
Su Advances in Charged Particle Therapy Machines
Holm Status report on the Gustaf Werner cyclotron in Uppsala